Hester Biosciences Limited Financial Overview
Hester Biosciences Limited's market cap is currently ₹13.47B. The company's EPS TTM is ₹16.985; its P/E ratio is 30.72; and it has a dividend yield of 0.44%. Hester Biosciences Limited is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
